Solventum Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022
Cash & Equivalents	194	61
Cash & Cash Equivalents	194	61
Cash Growth	218.03%	-
Receivables	1,313	1,171
Inventory	857	873
Other Current Assets	155	126
Total Current Assets	2,519	2,231
Property, Plant & Equipment	1,457	1,319
Goodwill and Intangibles	9,437	9,686
Other Long-Term Assets	530	358
Total Long-Term Assets	11,424	11,363
Total Assets	13,943	13,594
Accounts Payable	477	348
Deferred Revenue	574	559
Other Current Liabilities	677	404
Total Current Liabilities	1,728	1,311
Other Long-Term Liabilities	549	541
Total Long-Term Liabilities	549	541
Total Liabilities	2,277	1,852
Comprehensive Income	-337	-497
Shareholders' Equity	11,666	11,742
Net Cash / Debt	194	61
Net Cash / Debt Growth	218.03%	-
Working Capital	791	920
Book Value Per Share	67.64	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).